Back

Impact of temperature on the affinity of SARS-CoV-2 Spike for ACE2

Prevost, J.; Richard, J.; Gasser, R.; Ding, S.; Fage, C.; Anand, S. P.; Adam, D.; Gupta Vergara, N.; Tauzin, A.; Benlarbi, M.; Gong, S. Y.; Goyette, G.; Prive, A.; Moreira, S.; Charest, H.; Roger, M.; Mothes, W.; Pazgier, M.; Brochiero, E.; Boivin, G.; Abrams, C. F.; Schon, A.; Finzi, A.

2021-07-09 microbiology
10.1101/2021.07.09.451812 bioRxiv
Show abstract

The seasonal nature in the outbreaks of respiratory viral infections with increased transmission during low temperatures has been well established. The current COVID-19 pandemic makes no exception, and temperature has been suggested to play a role on the viability and transmissibility of SARS-CoV-2. The receptor binding domain (RBD) of the Spike glycoprotein binds to the angiotensin-converting enzyme 2 (ACE2) to initiate viral fusion. Studying the effect of temperature on the receptor-Spike interaction, we observed a significant and stepwise increase in RBD-ACE2 affinity at low temperatures, resulting in slower dissociation kinetics. This translated into enhanced interaction of the full Spike to ACE2 receptor and higher viral attachment at low temperatures. Interestingly, the RBD N501Y mutation, present in emerging variants of concern (VOCs) that are fueling the pandemic worldwide, bypassed this requirement. This data suggests that the acquisition of N501Y reflects an adaptation to warmer climates, a hypothesis that remains to be tested.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.